CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

Shares of Core Laboratories Inc. CLB gained momentum over the last month, following a staggering rise of 13% in just one month. During the same time period, the company’s shares outperformed the ...

HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of ...

Fintel reports that on March 12, 2025, Citigroup upgraded their outlook for Core Laboratories (NYSE:CLB) from Sell to Neutral. As of March 4, 2025, the average one-year price target for Core ...

Core Laboratories is in good financial health. At the last reporting period, the firm had $16 million of cash on hand and $180 million of long-term debt. 2022 net debt/adjusted EBITDA was elevated at ...

HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory ...

Good day, and welcome to the Core Laboratories Q3 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Larry Bruno, ...

HUNTSVILLE, Ala.--(BUSINESS WIRE)--Madison Core Laboratories (“MCL”) is pleased to announce the expansion of its clinical laboratory in Huntsville, Alabama. “This expansion increases our laboratory ...

probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...